Andrew Vallely1, Claire E Ryan2, Joyce Allen2, Joyce C Sauk3, Cassey S Simbiken2, Johanna Wapling2, Petronia Kaima4, Zure Kombati4, Greg Law5, Glenda Fehler6, John M Murray7, Peter Siba2, John M Kaldor1. 1. The Kirby Institute, University of New South Wales, Darlinghurst, NSW 2010, Australia. 2. Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea. 3. National Capital District Department of Health, Port Moresby, Papua New Guinea. 4. Mount Hagen General Hospital, Mount Hagen, Papua New Guinea. 5. National Department of Health, Port Moresby, Papua New Guinea. 6. Melbourne Sexual Health Centre, 580 Swanston Street, Carlton, Vic. 3053, Australia. 7. School of Mathematics and Statistics, University of New South Wales, Sydney, NSW 2052, Australia.
Abstract
UNLABELLED: Background Papua New Guinea (PNG) has one of the highest prevalences of HIV and sexually transmissible infections (STIs) in the Asia-Pacific region, and one of the highest burdens of maternal syphilis and cervical cancer globally. Despite this disease burden, only limited clinical research in sexual and reproductive health has been conducted in PNG. METHODS: A longitudinal clinical cohort study was conducted at two sexual health clinics. Participants completed a behavioural interview, clinical assessment and genital examination at baseline, and at 12, 24 and 50 weeks, including specimen collection for STI diagnostics. RESULTS: In total, 154 people attended a screening visit. Reattendance at 12, 24 and 50-weeks was 87%, 78% and 80% respectively. At baseline, HIV prevalence was 3.3%; chlamydia (Chlamydia trachomatis), 29.2%; gonorrhoea (Neisseria gonorrhoeae), 22.1%; Trichomonas vaginalis 15.6%; herpes simplex type-2 (HSV-2), 46.1%; active syphilis, 11.7%. Multiple infections were common particularly among women. The incidence of chlamydia was 27 per 100 person-years (PY); gonorrhoea, 15 out of 100 PY; T. vaginalis, 29 out of 100 PY; HSV-2, 12 out of 100 PY; syphilis, 8 out of 100 PY. No incident HIV cases were recorded. At baseline, 39% of men in Mt Hagen and 65% in Port Moresby had a penile foreskin cut, with a dorsal slit being the most common. Two men underwent penile cutting during the follow-up period. CONCLUSIONS: The prevalence and incidence of STIs, HIV and penile cutting were high among sexual health clinic attendees. High retention figures suggest that this population may be suitable for future interventions research and clinical trials.
UNLABELLED: Background Papua New Guinea (PNG) has one of the highest prevalences of HIV and sexually transmissible infections (STIs) in the Asia-Pacific region, and one of the highest burdens of maternal syphilis and cervical cancer globally. Despite this disease burden, only limited clinical research in sexual and reproductive health has been conducted in PNG. METHODS: A longitudinal clinical cohort study was conducted at two sexual health clinics. Participants completed a behavioural interview, clinical assessment and genital examination at baseline, and at 12, 24 and 50 weeks, including specimen collection for STI diagnostics. RESULTS: In total, 154 people attended a screening visit. Reattendance at 12, 24 and 50-weeks was 87%, 78% and 80% respectively. At baseline, HIV prevalence was 3.3%; chlamydia (Chlamydia trachomatis), 29.2%; gonorrhoea (Neisseria gonorrhoeae), 22.1%; Trichomonas vaginalis 15.6%; herpes simplex type-2 (HSV-2), 46.1%; active syphilis, 11.7%. Multiple infections were common particularly among women. The incidence of chlamydia was 27 per 100 person-years (PY); gonorrhoea, 15 out of 100 PY; T. vaginalis, 29 out of 100 PY; HSV-2, 12 out of 100 PY; syphilis, 8 out of 100 PY. No incident HIV cases were recorded. At baseline, 39% of men in Mt Hagen and 65% in Port Moresby had a penile foreskin cut, with a dorsal slit being the most common. Two men underwent penile cutting during the follow-up period. CONCLUSIONS: The prevalence and incidence of STIs, HIV and penile cutting were high among sexual health clinic attendees. High retention figures suggest that this population may be suitable for future interventions research and clinical trials.
Authors: Noemi B Hall; Shannon E Bruse; Bangan John; Rajeev K Mehlotra; Melinda J Blood Zikursh; Catherine M Stein; Peter M Siba; Peter A Zimmerman Journal: Infect Genet Evol Date: 2015-09-28 Impact factor: 3.342
Authors: Richard T Gray; Andrew Vallely; David P Wilson; John Kaldor; David MacLaren; Angela Kelly-Hanku; Peter Siba; John M Murray Journal: PLoS One Date: 2014-08-11 Impact factor: 3.240
Authors: David J MacLaren; W John H McBride; Gerard C Kelly; Reinhold Muller; Rachael Tommbe; John M Kaldor; Andrew J Vallely Journal: Sex Transm Infect Date: 2015-06-30 Impact factor: 3.519
Authors: Lisa M Vallely; Pamela Toliman; Claire Ryan; Glennis Rai; Johanna Wapling; Josephine Gabuzzi; Joyce Allen; Christine Opa; Gloria Munnull; Petronia Kaima; Benny Kombuk; Antonia Kumbia; Zure Kombati; Greg Law; Angela Kelly-Hanku; Handan Wand; Peter M Siba; Glen D L Mola; John M Kaldor; Andrew J Vallely Journal: BMJ Open Date: 2017-12-29 Impact factor: 2.692
Authors: Andrew J Vallely; David MacLaren; Matthew David; Pamela Toliman; Angela Kelly-Hanku; Ben Toto; Rachael Tommbe; Zure Kombati; Petronia Kaima; Kelwyn Browne; Clement Manineng; Lalen Simeon; Claire Ryan; Handan Wand; Peter Hill; Greg Law; Peter M Siba; W John H McBride; John M Kaldor Journal: J Int AIDS Soc Date: 2017-04-03 Impact factor: 5.396
Authors: Shepherd Machekera; Peniel Boas; Poruan Temu; Zimmbodilion Mosende; Namarola Lote; Angela Kelly-Hanku; S Guy Mahiane; Robert Glaubius; Jane Rowley; Anup Gurung; Eline Korenromp Journal: Infect Dis Model Date: 2021-03-20